chronic obstructive pulmonary disease
Conditions
Interventions
Control group:Conventional drug use, lifestyle intervention and Baduanjin exercise education
Conventional pulmonary rehabilitation group:On the basis of the control group, conventional outpatient pulmonary rehabilitation was given
Baduanjin group:On the basis of the control group, the smart phone remote rehabilitation software was used to watch Baduanjin video for Baduanjin training
Sponsors
The First Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Male/female subjects aged 40-75 yearsfemale Subjects for this study must meet ALL of the following criteria: a. No potential fertility, who are physiologically incapable of pregnancy, including women who have been menopausal for 2 years; b. Have potential for fertility, the result of the serum pregnancy test was negative at the time of the visit, and agree to insist on the corrective treatment with an acceptable method of contraception during the visit until the end of the final visit; (2) Participants must meet the diagnostic criteria for COPD, and in a clinically stable phase, with no respiratory infection and acute episodes of chronic obstructive pulmonary disease in the past 4 weeks; (3) Participants are capable to complete the pulmonary function test, moderate to severe patients will be enrolled. (4) Those who can perform the Baduanjin exercise; (5) Own and use a smart phone/computer; (6) Did not participate in other clinical trials at the same time; (7) No daily exercise habits, such as Baduanjin, Tai Chi, aerobic exercises, etc.; (8) Obtain the consent from the subjects, family members, guardians or legal representatives and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Airway obstruction caused by asthma or other non-chronic obstructive pulmonary diseases; (2) Congestive heart failure, heart function NYHA grade III or above; (3) Resting heart rate > 100 beats/min; (4) FEV1 > 80% predicted value; FEV1 = 160/100mmHg); uncontrolled diabetes (random blood glucose > 16.7 mmol/l, glycosylated hemoglobin > 7.0%); (6) Late-stage tumor or severe disease; (7) Patients with unstable ischemic heart disease, left heart failure, and myocardial infarction within 6 months before enrollment can not be stably controlled; within the past 3 months, patients with acute coronary syndrome or receiving or percutaneous coronary intervention therapy or coronary artery bypass graft surgery; (8) Joints, peripheral blood vessels and neuropathy that lack of basic exercise ability; (9) Mental cognitive impairment; (10) Those with poor compliance that can hardly cooperate with assessment, treatment and training; (11) Women who are breastfeeding or pregnant, or plan to become pregnant during the study period, or women who are fertile but fail to use effective contraceptive methods; (12) Subjects participate in a pulmonary rehabilitation program within 4 weeks before enrollment, or plan to participate in other pulmonary rehabilitation programs during the study period; (13) Subjects combined with severe liver and kidney disease (severe liver disease refers to cirrhosis, portal hypertension and bleeding from varicose veins, severe kidney disease includes dialysis, kidney transplantation).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| pulmonary function;high resolution CT of the chest;mMRC;strength of lower extremity muscles;SF-36; | — |
Primary
| Measure | Time frame |
|---|---|
| Total distances of 6MWT;SGRQ; | — |
Countries
China
Contacts
Public ContactZhou Linfu
The First Affiliated Hospital of Nanjing Medical University
Outcome results
None listed